Get started
Author

Sofia Grigoriadou

Observed names: Grigoriadou, Sofia, S Grigoriadou, S. Grigoriadou
Observed institutions: University of London, National Health Service, University Hospitals Birmingham NHS Foundation Trust, Queen Mary University of London, Royal Free London NHS Foundation Trust, King's College London, Barts Health NHS Trust, University of Cambridge, Royal Brompton & Harefield NHS Foundation Trust, Great Ormond Street Hospital, Maastricht University Medical Centre, Royal London Hospital, University Hospitals of Leicester NHS Trust, King's College Hospital NHS Foundation Trust, William Harvey Research Institute, Moorfields Eye Hospital, Addenbrooke's Hospital, University College London, Newcastle University, Wellcome Trust
ORCID: 0000-0002-0265-5014
Observed ORCIDs: 0000-0002-0265-5014, 0000-0002-9863-425X
OpenAlex ID: A5066280761
A robust model for read count data in exome sequencing experiments and implications for copy number variant calling
2012 · Vincent Plagnol, James Curtis, et al. · Bioinformatics · 743
PDF
The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity
2019 · Markus G. Seidel, Gerhard Kindle, et al. · The Journal of Allergy and Clinical Immunology In Practice · 639
PDF
Whole-genome sequencing of patients with rare diseases in a national health system
2020 · Ernest Turro, William J. Astle, et al. · Nature · 567
PDF
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493
Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease
2016 · Keren J. Carss, Gavin Arno, et al. · The American Journal of Human Genetics · 463
Primary B Cell Immunodeficiencies: Comparisons and Contrasts
2009 · Mary Ellen Conley, A. Kerry Dobbs, et al. · Annual Review of Immunology · 426
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290
Whole-genome sequencing of a sporadic primary immunodeficiency cohort
2020 · James E. D. Thaventhiran, Hana Lango Allen, et al. · Nature · 240
PDF
Germline selection shapes human mitochondrial DNA diversity
2019 · Wei Wei, Salih Tuna, et al. · Science · 236
Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans
2018 · Paul Tuijnenburg, Hana Lango Allen, et al. · Journal of Allergy and Clinical Immunology · 233
PDF
COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
2020 · Adrian M. Shields, Siobhan O. Burns, et al. · Journal of Allergy and Clinical Immunology · 220
PDF
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
2021 · Julian Thalhammer, Gerhard Kindle, et al. · Journal of Allergy and Clinical Immunology · 170
PDF
Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management
2011 · C Gholam, S Grigoriadou, et al. · Clinical & Experimental Immunology · 168
HAE international home therapy consensus document
2010 · Hilary J Longhurst, Henriette Farkas, et al. · Allergy Asthma and Clinical Immunology · 166
PDF
Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension
2017 · Charaka Hadinnapola, Marta Bleda, et al. · Circulation · 147
Hypogammaglobulinaemia after rituximab treatment--incidence and outcomes
2014 · M. Makatsori, S. Kiani-Alikhan, et al. · QJM · 144
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations
2020 · Tiziana Lorenzini, Manfred Fliegauf, et al. · Journal of Allergy and Clinical Immunology · 140
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
2020 · Matthew S. Buckland, James B. Galloway, et al. · Nature Communications · 118
PDF
The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008–2012
2013 · J D M Edgar, M Buckland, et al. · Clinical & Experimental Immunology · 105
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data
2018 · James H. R. Farmery, Mike L. Smith, et al. · Scientific Reports · 88
PDF
Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement
2014 · Sai S. Duraisingham, Matthew Buckland, et al. · PLoS ONE · 86
PDF
Works count: 106
Citation count: 8,855
H-index: 40
I10-index: 64
Year
Topic
Type